Larimar Therapeutics (LRMR) Capital Expenditures Growth (1y) (2014 - 2025)
Larimar Therapeutics (LRMR) Capital Expenditures Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | -110.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -110.61% |
| Sep 30, 2025 | -133.98% |
| Jun 30, 2025 | 295.24% |
| Mar 31, 2025 | -173.68% |
| Dec 31, 2024 | 6.55% |
| Sep 30, 2024 | 3,690.00% |
| Jun 30, 2024 | -450.00% |
| Mar 31, 2024 | 416.67% |
| Dec 31, 2023 | 3,460.00% |
| Sep 30, 2023 | 92.06% |
| Jun 30, 2023 | -88.12% |
| Mar 31, 2023 | -500.00% |
| Dec 31, 2022 | -101.54% |
| Sep 30, 2022 | 48.36% |
| Jun 30, 2022 | 229.49% |
| Mar 31, 2022 | -100.30% |
| Dec 31, 2021 | 27.06% |
| Sep 30, 2021 | -4,980.00% |
| Jun 30, 2021 | -236.84% |
| Mar 31, 2021 | 33,000.00% |